Inventor · disambiguated record
Larry Wendell Hardy
Also filed as: HARDY LARRY W · HARDY LARRY WENDELL
14 granted patents·7 pending applications·40 citations·filing 2006–2018
88Inventor score
Files withSUNOVION PHARMACEUTICALS INC12HANDLEY DEAN A2HEFFERNAN MICHELE L R2SHAO LIMING2BURDI DOUGLAS1
Top patents by PatentIndex Score
21 records- 0191US8053603B2Tetralone-based monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2006·Granted Nov 8, 2011·24 cites·23 claims
- 0289US8772301B2Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofHARDY LARRY WENDELL·Filed 2010·Granted Jul 8, 2014·13 cites·32 claims
- 0377US8669291B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2008·Granted Mar 11, 2014·2 cites·19 claims
- 0469US8877975B2Cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2010·Granted Nov 4, 2014·1 cites·23 claims
- 0568US10640510B2Metabotrophic glutamate receptor 5 modulators and methods use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·0 cites·6 claims
- 0666US10077243B2Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Sep 18, 2018·0 cites·11 claims
- 0766US9586888B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·0 cites·27 claims
- 0865US9868718B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·0 cites·2 claims
- 0963US10196399B2Metabotrophic glutamate receptor 5 modulators and methods use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·0 cites·9 claims
- 1063US2017204050A1Phenyl substituted cycloalkylamines as monoamine reputake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1162US2019055204A1Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1260US9708331B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·0 cites·15 claims
- 1360US2007203111A1Cycloalkylamines as monoamine reuptake inhibitorsSEPRACOR INC·Filed 2007·Application pending·0 cites
- 1459US2008293823A1Methods and Compositions For Treating Sleep-Related Breathing DisordersHANDLEY DEAN A·Filed 2008·Application pending·0 cites
- 1557US10562878B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·0 cites·26 claims
- 1656US9260452B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofHEFFERNAN MICHELE L R·Filed 2012·Granted Feb 16, 2016·0 cites·18 claims
- 1751US2012238616A1Methods and compositions for treating sleep-related breathing disordersHANDLEY DEAN A·Filed 2012·Application pending·0 cites
- 1845US2015196531A1Methods and Compositions For Treating Sleep-Related Breathing DisordersSUNOVION PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1941US11186564B2Dual NAV1.2/5HT2a inhibitors for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Nov 30, 2021·0 cites·11 claims
- 2035US10533000B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofHEFFERNAN MICHELE L R·Filed 2012·Granted Jan 14, 2020·0 cites·14 claims
- 2133US2012029190A1Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofBURDI DOUGLAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Larry Wendell Hardy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →